Holding CURE?
Track your performance easily

CURE Price & Analysis

CURE ETF Chart & Stats

Direxion Daily Healthcare Bull 3x Shares (CURE) Fund Flow Chart

Direxion Daily Healthcare Bull 3x Shares (CURE) 1 year Net Flows: -57M

CURE ETF FAQ

What was CURE’s price range in the past 12 months?
CURE lowest ETF price was 75.39 and its highest was 143.51 in the past 12 months.
    What is the AUM of CURE?
    As of Sep 17, 2024 The AUM of CURE is 204.68M.
      Is CURE overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does CURE pay dividends?
      CURE pays a Quarterly dividend of 0.27 which represents an annual dividend yield of N/A. See more information on CURE dividends here
        How many shares outstanding does CURE have?
        CURE has 1,450,008 shares outstanding.
          Which hedge fund is a major shareholder of CURE?
          Currently, no hedge funds are holding shares in CURE

          Top 10 Holdings

          Name
          Weight %
          Eli Lilly And Company
          11.49%
          USD_CASH
          U.S. Dollar
          10.49%
          Unitedhealth Group Inc.
          8.44%
          Johnson & Johnson
          6.38%
          Abbvie
          5.42%
          Merck & Company
          4.76%
          Thermo Fisher Scientific
          3.70%
          Abbott Laboratories
          3.26%
          Danaher Corporation
          2.85%
          Amgen Inc
          2.83%
          Total59.63%

          ETF Description

          Direxion Daily Healthcare Bull 3x Shares

          CURE provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies.
          Sector
          Sector
          Asset Class
          Equity
          Region
          North America
          Issuer
          Direxion
          Index Tracked
          Health Care Select Sector
          Ticker Symbol
          CURE
          Popular ETFs
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis